EndoQuest Robotics
Enabling Endoluminal and Single-Incision Surgery
Houston, United States · Founded 2017 · $84.0M raised
- Headquarters
- Houston, Texas
- Employees
- 51–200
- Founded
- 2017
- Business Model
- B2B
- Website
- endoquestrobotics.com
- Total Funding
- $84.0M
- Last Round
- $42.0M Series DJul 2025
- Rounds
- 2
About
EndoQuest Robotics is a Houston, Texas-based medical robotics company founded in 2017 that is developing the world's first flexible robotic surgery system for endoluminal and single-incision procedures. The system enables surgery through the body's natural orifices (mouth and anus) or a transumbilical incision, eliminating the need for external incisions required by conventional laparoscopic or robotic surgery. The company has raised over $232 million across six funding rounds, including a Series D-2 round in 2025 co-led by Crescent Enterprises and Dr. Fred Moll.
Summary
EndoQuest Robotics is a Biotech company based in Houston, United States, founded in 2017. It has raised $84.0M in total across 2 rounds, most recently a $42.0M Series D round in Jul 2025. Investors include Crescent Enterprises, Fred Moll and CE Ventures.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biopharmaceutical services company

Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.